Biolife Solutions
(BLFS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 139 | 99 | 57 | 310 | 185 |
| Receivables | 315 | 279 | 301 | 99 | 76 |
| Inventories | 358 | 625 | 99 | 93 | 123 |
| TOTAL | $892 | $1,023 | $570 | $516 | $385 |
| Non-Current Assets | |||||
| PPE Net | 405 | 130 | 113 | 45 | 62 |
| Other Non-Current Assets | 36 | 18 | 44 | 0 | 0 |
| TOTAL | $442 | $148 | $156 | $45 | $62 |
| Total Assets | $1,334 | $1,171 | $726 | $560 | $447 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 193 | 659 | 97 | 90 | 66 |
| Accrued Expenses | 144 | 242 | 340 | 93 | 117 |
| TOTAL | $357 | $927 | $446 | $380 | $211 |
| Non-Current Liabilities | |||||
| Long Term Debt | 7,888 | 5,063 | 2,750 | N/A | 198 |
| Deferred Revenues | 20 | 26 | 8 | N/A | N/A |
| Other Non-Current Liabilities | 767 | 279 | 0 | 0 | 0 |
| TOTAL | $8,804 | $5,415 | $2,750 | $N/A | $198 |
| Total Liabilities | $9,161 | $6,342 | $3,196 | $380 | $409 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,975 | 4,972 | 4,970 | 4,970 | 886 |
| Common Shares | 70 | 70 | 70 | 69 | 12 |
| Retained earnings | -50,211 | -47,443 | -44,668 | -41,816 | -40,682 |
| Other shareholders' equity | 0 | 0 | 0 | -9 | -31 |
| TOTAL | $-7,827 | $-5,171 | $-2,470 | $180 | $39 |
| Total Liabilities And Equity | $1,334 | $1,171 | $726 | $560 | $447 |